Biomarker World Congress 2005.
This report covers some of the many excellent talks, and a selected number of posters, that were presented at this conference. It includes several emerging issues in biomarker development and the question of how biomarker science can drive targeted drug discovery and development and form a scientific basis for personalized medicine. Although relatively small, the meeting provided a good opportunity for business networking, particularly for those involved in the development and regulation of medical diagnostics and biopharmaceuticals.
Yeung
Pollen K F
PK
Dalhousie University, Pharmacokinetics and Metabolism Laboratory, School of Pharmacy, Burbridge Building, Halifax, NS, Canada. pollen.yeung@dal.ca
D000818:Animals; D015415:Biomarkers; D001709:Biotechnology; D003933:Diagnosis; D004351:Drug Resistance; D023281:Genomics; D006801:Humans; D007511:Ischemia / Q000175:diagnosis / Q000188:drug therapy; D009369:Neoplasms / Q000175:diagnosis / Q000517:prevention & control; D010600:Pharmacology / Q000639:trends
D015415:Biomarkers